For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Smithkline Beckman Corporation

USPTO Granted Patents = 207

Trademarks = 5

Forward Citations = 1,794

Loading Chart...

Loading Chart...

167 inventors (with patents filed for the assignee):

Lawrence I Kruse (28 out of 45 patents)

Carl Kaiser (19 out of 46 patents)

William F Huffman (19 out of 47 patents)

4. Michael L Moore (14 out of 20 patents)

5. Joseph Weinstock (14 out of 65 patents)

6. Nelson C Yim (13 out of 20 patents)

7. David T Hill (13 out of 43 patents)

8. Paul E Bender (10 out of 44 patents)

9. John G Gleason (10 out of 66 patents)

10. Stephen T Ross (10 out of 21 patents)

11. Randall K Johnson (9 out of 19 patents)

12. Robert M DeMarinis (9 out of 35 patents)

13. Fadia E Ali (9 out of 19 patents)

14. James Francis Callahan (8 out of 64 patents)

15. Robert D Sitrin (7 out of 11 patents)

Core Competencies:

Protein Protease Inhibitors

Porcine Growth Hormone Analogs

Dopamine Beta-Hydroxylase Inhibitors

Steroid 5-Alpha-Reductase Inhibitors

Leukotriene Antagonists

Tumor Cell Growth Inhibitors

Vasopressin Compounds

Antitumor Compounds

Fluorescent Calcium Indicators

Polynucleotide Hybridization Probes

Epoxy Esters

Immunomodulation

207 patents: Sort by Forward Citations

1. 5498529 - Protein protease inhibitors from streptomyces (1996-03-12),

2. 5422274 - Internal deletion mutants of soluble T4(CD4) (1995-06-06),

3. 5356877 - Methods for promoting growth using porcine growth hormone analogs (1994-10-18),

4. 5110959 - Process for preparation of epoxy esters and intermediates prepared (1992-05-05),

5. 5110906 - Derivatives of soluble T-4 (1992-05-05),

6. 5037812 - Tumor cell growth-inhibiting pharmaceutical compositions containing (1991-08-06),

7. 5008390 - Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and (1991-04-16),

8. 4937237 - Phosphinic acid substituted aromatic steroids as inhibitors of steroid (1990-06-26),

9. 4935438 - Dopamine-.beta.-hydroxylase inhibitors (1990-06-19),

10. 4912226 - Intermediate to dopamine-.beta.-hydroxylase inhibitors (1990-03-27),

11. 4910226 - Steroid 5-alpha-reductase inhibitors (1990-03-20),

12. 4908475 - Intermediates for preparing 1,6-dicarba-vasopressin compounds (1990-03-13),

13. D306347 - Delayed action dosage unit for releasing medicaments or the like in (1990-02-27),

14. 4902675 - '2-pyridyl and 4-pyridyl phosphine gold (I) anti tumor complexes' (1990-02-20),

15. 4888336 - Steroid 5-alpha-reductase inhibitors (1989-12-19),

SmithKline Beckman Corporation is a pharmaceutical company that focuses on research, development, and manufacturing of healthcare products. With a rich history spanning over several decades, SmithKline Beckman Corporation has consistently aimed to improve global health by providing innovative solutions. The company is committed to delivering high-quality pharmaceuticals, vaccines, and consumer healthcare products to enhance the well-being of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

207 Patents

#14 in Philadelphia, PA

#83 in Pennsylvania

#1,935 in US

#3,993 in the World

Philadelphia, PA, United States of America

Smithkline Beckman Corporation

Forward Citations = 1,794

167 inventors:

Lawrence I Kruse (28 out of 45 patents)

Carl Kaiser (19 out of 46 patents)

William F Huffman (19 out of 47 patents)

4. Michael L Moore (14 out of 20 patents)

5. Joseph Weinstock (14 out of 65 patents)

Please report any incorrect information to support@idiyas.com

Loading…